Close Menu
July 16, 2020
Sponsored by
NanoString

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

GenomeWebinar

Assistant Professor of Clinical Dermatology,
University of California, Davis

Instructor in Radiation Oncology, Massachusetts General Hospital, Harvard Medical School; Associate Scientist, Broad Institute of MIT and Harvard

Senior Scientist,
NanoString Technologies

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response

Digital spatial profiling of immuno-oncology targets in the tumor, microenvironment, and immune compartments of archival formalin-fixed, paraffin-embedded tissue sections is coupled to downstream next-generation sequencing (NGS) readout. Our speakers will discuss how the NGS readout enables high-throughput and high-plex spatial analysis.

Our first speaker, Margaret Hoang, Senior Scientist, NanoString Technologies will provide a high level overview of the GeoMx Digital Spatial Profiler (DSP), which delivers quantitative high plex, multi-analyte spatial profiling using NGS readout.

Maija Kiuru of the University of California, Davis, will share details of a study that used NanoString’s GeoMx Cancer Transcriptome Atlas to reveal microenvironment-specific expression of a novel cell-type specific biomarker, DAMP, in response to early melanoma development. This marker may allow for more sensitive detection of melanoma via patch biopsy. 

William Hwang of the Broad Institute will then discuss how his team used GeoMx Cancer Transcriptome Atlas and Whole Transcriptome Atlas applications to profile tumor, fibroblast, and immune compartments in pancreatic ductal adenocarcinoma (PDAC) samples from twelve patients. Differential gene expression was measured in tumor and fibroblast compartments between treatment groups and by levels of immune infiltration.

Sponsored by

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
16
Sponsored by
NanoString

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response. 

Jul
22
Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
29
Sponsored by
Illumina

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.